CVS Health Corporation Stock Price, News & Analysis (NYSE:CVS)

$71.50 1.12 (1.59 %)
(As of 11/21/2017 04:00 PM ET)
Previous Close$70.38
Today's Range$70.53 - $71.63
52-Week Range$66.45 - $84.72
Volume9.61 million shs
Average Volume6.64 million shs
Market Capitalization$72.43 billion
P/E Ratio12.38
Dividend Yield2.83%
Beta0.86

About CVS Health Corporation (NYSE:CVS)

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.


Industry, Sector and Symbol:
  • Industry: Drug Retailers
  • Sub-Industry: Drug Retail
  • Sector: Non-Cyclical Consumer Goods & Services
  • Symbol: NYSE:CVS
  • CUSIP: 12665010
  • Web: www.cvshealth.com
Debt:
  • Debt-to-Equity Ratio: 0.67%
  • Current Ratio: 1.05%
  • Quick Ratio: 0.55%
Price-To-Earnings:
  • Trailing P/E Ratio: 12.38
  • Forward P/E Ratio: 12.12
  • P/E Growth: 1.21
Sales & Book Value:
  • Annual Sales: $177.53 billion
  • Price / Sales: 0.41
  • Cash Flow: $8.32 per share
  • Price / Cash: 8.59
  • Book Value: $34.54 per share
  • Price / Book: 2.07
Dividend:
  • Annual Dividend: $2.00
  • Dividend Yield: 2.8%
Profitability:
  • Trailing EPS: $4.84
  • Net Income: $5.32 billion
  • Net Margins: 2.77%
  • Return on Equity: 16.96%
  • Return on Assets: 6.36%
Misc:
  • Employees: 250,000
  • Outstanding Shares: 1,012,990,000
 

Frequently Asked Questions for CVS Health Corporation (NYSE:CVS)

What is CVS Health Corporation's stock symbol?

CVS Health Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health Corporation pay dividends? What is the dividend yield for CVS Health Corporation?

CVS Health Corporation announced a quarterly dividend on Tuesday, September 19th. Stockholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share on Friday, November 3rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.80%. The ex-dividend date of this dividend is Monday, October 23rd. View CVS Health Corporation's Dividend History.

How were CVS Health Corporation's earnings last quarter?

CVS Health Corporation (NYSE:CVS) issued its quarterly earnings data on Monday, November, 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.01. The pharmacy operator earned $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The company's revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.64 earnings per share. View CVS Health Corporation's Earnings History.

When will CVS Health Corporation make its next earnings announcement?

CVS Health Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, February, 7th 2018. View Earnings Estimates for CVS Health Corporation.

What guidance has CVS Health Corporation issued on next quarter's earnings?

CVS Health Corporation updated its fourth quarter earnings guidance on Monday, November, 6th. The company provided earnings per share (EPS) guidance of $1.88-1.92 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.91.

Where is CVS Health Corporation's stock going? Where will CVS Health Corporation's stock price be in 2017?

19 analysts have issued 12 month price targets for CVS Health Corporation's stock. Their forecasts range from $73.00 to $106.67. On average, they expect CVS Health Corporation's share price to reach $85.51 in the next year. View Analyst Ratings for CVS Health Corporation.

What are Wall Street analysts saying about CVS Health Corporation stock?

Here are some recent quotes from research analysts about CVS Health Corporation stock:

  • 1. Guggenheim analysts commented, " Our recent meetings with CEO Larry Merlo, CFO Dave Denton, and VP-IR Nancy Christal further reinforced our confidence in 10% secular growth, which we believe the market is currently undervaluing, at a 13x P/E on somewhat depressed 2017E EPS. Bottom line, even in the face of secular gross margin erosion, in both segments, we believe the company should be able to grow EBIT by 5% on the back of a) natural growth in specialty Rx, b) increasingly rapid product innovation, c) a broadening set of productive relationships, and d) both COGS and SG&A reductions. In our view, this growth merits a valuation closer to a market multiple'we reiterate our Buy rating and $90 PT, implying 15% upside from current levels." (3/28/2017)
  • 2. Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)

Are investors shorting CVS Health Corporation?

CVS Health Corporation saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 24,837,344 shares, an increase of 16.1% from the October 13th total of 21,400,669 shares. Based on an average daily trading volume, of 10,995,147 shares, the days-to-cover ratio is presently 2.3 days. Currently, 2.5% of the shares of the company are short sold.

Who are some of CVS Health Corporation's key competitors?

Who are CVS Health Corporation's key executives?

CVS Health Corporation's management team includes the folowing people:

  • David Wyatt Dorman, Independent Chairman of the Board (Age 63)
  • Larry J. Merlo, President, Chief Executive Officer, Director (Age 61)
  • David M. Denton, Chief Financial Officer, Executive Vice President (Age 52)
  • Jonathan C. Roberts, Chief Operating Officer, Executive Vice President (Age 61)
  • Lisa G. Bisaccia, Chief Human Resource Officer, Executive Vice President (Age 60)
  • Stephen J. Gold, Executive Vice President, Chief Information Officer (Age 57)
  • Thomas M. Moriarty, Executive Vice President, General Counsel, Chief Health Strategy Officer (Age 53)
  • Troyen A. Brennan M.D., Executive Vice President, Chief Medical Officer (Age 62)
  • Helena B. Foulkes, Executive Vice President, President of CVS - Pharmacy (Age 52)
  • J. David Joyner, Executive Vice President (Age 52)

Who owns CVS Health Corporation stock?

CVS Health Corporation's stock is owned by many different of institutional and retail investors. Top institutional investors include Nordea Investment Management AB (1.39%), Dimensional Fund Advisors LP (1.07%), Bank of New York Mellon Corp (1.04%), Macquarie Group Ltd. (0.87%), Veritas Asset Management LLP (0.85%) and Ameriprise Financial Inc. (0.78%). Company insiders that own CVS Health Corporation stock include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Richard J Swift, Stephen J Gold, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health Corporation.

Who sold CVS Health Corporation stock? Who is selling CVS Health Corporation stock?

CVS Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including Caisse DE Depot ET Placement DU Quebec, Macquarie Group Ltd., Canada Pension Plan Investment Board, Amundi Pioneer Asset Management Inc., Retirement Systems of Alabama, CI Investments Inc., Swedbank and Cambiar Investors LLC. Company insiders that have sold CVS Health Corporation company stock in the last year include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Insider Buying and Selling for CVS Health Corporation.

Who bought CVS Health Corporation stock? Who is buying CVS Health Corporation stock?

CVS Health Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Truepoint Inc., Ameriprise Financial Inc., Stifel Financial Corp, Boston Partners, American Century Companies Inc., Bank of New York Mellon Corp, Legal & General Group Plc and Dimensional Fund Advisors LP. View Insider Buying and Selling for CVS Health Corporation.

How do I buy CVS Health Corporation stock?

Shares of CVS Health Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health Corporation's stock price today?

One share of CVS Health Corporation stock can currently be purchased for approximately $71.50.

How big of a company is CVS Health Corporation?

CVS Health Corporation has a market capitalization of $72.43 billion and generates $177.53 billion in revenue each year. The pharmacy operator earns $5.32 billion in net income (profit) each year or $4.84 on an earnings per share basis. CVS Health Corporation employs 250,000 workers across the globe.

How can I contact CVS Health Corporation?

CVS Health Corporation's mailing address is 1 Cvs Dr, WOONSOCKET, RI 02895-6146, United States. The pharmacy operator can be reached via phone at +1-401-7651500 or via email at [email protected]


MarketBeat Community Rating for CVS Health Corporation (NYSE CVS)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  872 (Vote Outperform)
Underperform Votes:  382 (Vote Underperform)
Total Votes:  1,254
MarketBeat's community ratings are surveys of what our community members think about CVS Health Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for CVS Health Corporation (NYSE:CVS)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 7 Hold Ratings, 12 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $85.51 (19.59% upside)

Consensus Price Target History for CVS Health Corporation (NYSE:CVS)

Price Target History for CVS Health Corporation (NYSE:CVS)

Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/10/2017Needham & Company LLCUpgradeHold -> Buy$69.02 -> $79.00N/AView Rating Details
11/7/2017Loop CapitalLower Price TargetHold$83.00 -> $73.00N/AView Rating Details
11/7/2017Jefferies Group LLCLower Price TargetHold$86.00 -> $76.00N/AView Rating Details
11/7/2017Leerink SwannReiterated RatingHold -> Outperform$90.00 -> $85.00N/AView Rating Details
11/3/2017Citigroup Inc.Lower Price TargetNeutral$87.00 -> $74.00N/AView Rating Details
10/29/2017Cowen and CompanySet Price TargetBuy$86.00N/AView Rating Details
10/27/2017Robert W. BairdReiterated RatingHold$77.00N/AView Rating Details
10/24/2017MizuhoSet Price TargetBuy$90.00N/AView Rating Details
10/12/2017SunTrust Banks, Inc.Set Price TargetBuy$85.00N/AView Rating Details
10/9/2017Oppenheimer Holdings, Inc.Reiterated RatingBuy$95.00N/AView Rating Details
9/19/2017Royal Bank Of CanadaInitiated CoverageOutperform -> Outperform$95.00LowView Rating Details
8/14/2017Wolfe ResearchDowngradeOutperform -> Market Perform$89.00 -> $82.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
4/27/2017Tigress FinancialInitiated CoverageBuy -> BuyLowView Rating Details
2/28/2017Bank of America CorporationReiterated RatingBuy$106.67N/AView Rating Details
2/8/2017Deutsche Bank AGReiterated RatingHold$88.00N/AView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016Barclays PLCReiterated RatingBuy$85.00N/AView Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
2/10/2016Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$106.00 -> $110.00N/AView Rating Details
(Data available from 11/21/2015 forward)

Earnings

Earnings History and Estimates Chart for CVS Health Corporation (NYSE:CVS)

Earnings by Quarter for CVS Health Corporation (NYSE:CVS)

Earnings History by Quarter for CVS Health Corporation (NYSE CVS)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2018N/AView Earnings Details
11/6/2017Q3 2017$1.49$1.50$46.17 billion$46.18 billionViewN/AView Earnings Details
8/8/2017Q2 2017$1.31$1.33$45.36 billion$45.69 billionViewListenView Earnings Details
5/2/2017Q1 2017$1.10$1.17$44.20 billion$44.51 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CVS Health Corporation (NYSE:CVS)
2017 EPS Consensus Estimate: $5.90
2018 EPS Consensus Estimate: $6.46
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$1.09$1.33$1.18
Q2 20174$1.30$1.32$1.31
Q3 20175$1.47$1.64$1.51
Q4 20175$1.88$1.90$1.89
Q1 20185$1.12$1.49$1.28
Q2 20185$1.42$1.62$1.47
Q3 20184$1.63$1.82$1.70
Q4 20184$1.97$2.07$2.01
Q1 20192$1.24$1.34$1.29
Q2 20192$1.54$1.59$1.57
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for CVS Health Corporation (NYSE:CVS)

Most Recent Dividend:11/3/2017
Annual Dividend:$2.00
Dividend Yield:2.80%
Dividend Growth:23.60% (3 Year Average)
Payout Ratio:41.32% (Trailing 12 Months of Earnings)
33.90% (Based on This Year's Estimates)
31.50% (Based on Next Year's Estimates)
Track Record:9 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for CVS Health Corporation (NYSE:CVS)

Dividend History by Quarter for CVS Health Corporation (NYSE CVS)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/19/2017quarterly$0.502.48%10/23/201710/24/201711/3/2017
7/6/2017quarterly$0.502.54%7/20/20177/24/20178/3/2017
3/2/2017quarterly$0.502.47%4/19/20174/21/20175/1/2017
12/22/2016quarterly$0.502.54%1/20/20171/24/20172/2/2017
9/22/2016quarterly$0.431.88%10/20/201610/24/201611/3/2016
7/6/2016quarterly$0.431.78%7/19/20167/21/20168/1/2016
3/2/2016quarterly$0.431.71%4/20/20164/22/20165/2/2016
12/16/2015quarterly$0.431.79%1/20/20161/22/20162/2/2016
10/1/2015quarterly$0.351.41%10/20/201510/22/201511/2/2015
7/8/2015quarterly$0.351.32%7/21/20157/23/20158/3/2015
3/4/2015quarterly$0.351.35%4/22/20154/24/20155/4/2015
12/17/2014quarterly$0.351.49%1/20/20151/22/20152/2/2015
9/24/2014quarterly$0.281.38%10/21/201410/23/201411/3/2014
7/10/2014quarterly$0.281.43%7/17/20147/21/20148/1/2014
3/6/2014quarterly$0.281.5%4/17/20144/22/20145/2/2014
12/18/2013quarterly$0.281.57%1/21/20141/23/20142/3/2014
9/25/2013quarterly$0.231.55%10/17/201310/21/201311/1/2013
7/10/2013quarterly$0.231.48%7/18/20137/22/20138/2/2013
3/6/2013quarterly$0.231.73%4/19/20134/23/20135/3/2013
12/13/2012quarterly$0.231.83%1/22/20131/24/20132/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for CVS Health Corporation (NYSE CVS)

Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 81.42%
Insider Trades by Quarter for CVS Health Corporation (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Insider Trades by Quarter for CVS Health Corporation (NYSE CVS)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2017Thomas M MoriartyEVPSell20,547$81.17$1,667,799.99View SEC Filing  
9/18/2017Jonathan C RobertsCOOSell85,743$83.14$7,128,673.02View SEC Filing  
9/15/2017Helena FoulkesEVPSell39,340$81.88$3,221,159.20View SEC Filing  
9/13/2017Larry J MerloInsiderSell241,150$83.07$20,032,330.50View SEC Filing  
9/11/2017David M DentonCFOSell237,078$79.65$18,883,262.70View SEC Filing  
9/11/2017Thomas M MoriartyEVPSell90,267$79.61$7,186,155.87View SEC Filing  
8/16/2017Richard J SwiftDirectorSell2,500$79.62$199,050.00View SEC Filing  
6/26/2017Helena FoulkesEVPSell20,333$80.00$1,626,640.00View SEC Filing  
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.36View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.77View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.40View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.60View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.00View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for CVS Health Corporation (NYSE CVS)

Source:
DateHeadline
CVS Pharmacys Exclusive Black Friday and Cyber Monday promotions help customers save time and money, and find joy in the little things that matter mostCVS Pharmacy's Exclusive Black Friday and Cyber Monday promotions help customers save time and money, and find joy in the little things that matter most
finance.yahoo.com - November 21 at 5:51 PM
5 Bargain Stocks Trading at Ridiculously Low P/S Ratios5 Bargain Stocks Trading at Ridiculously Low P/S Ratios
finance.yahoo.com - November 21 at 5:51 PM
CVS-Aetna Deal Could Arrive This Month, WSJ ReportsCVS-Aetna Deal Could Arrive This Month, WSJ Reports
www.thestreet.com - November 20 at 6:42 PM
Better Buy: CVS Health Corporation vs. Wal-Mart - Motley FoolBetter Buy: CVS Health Corporation vs. Wal-Mart - Motley Fool
www.fool.com - November 17 at 1:40 PM
ETFs with exposure to CVS Health Corp. : November 17, 2017ETFs with exposure to CVS Health Corp. : November 17, 2017
finance.yahoo.com - November 17 at 1:40 PM
Earnings Preview: What To Expect From CVS On MondayEarnings Preview: What To Expect From CVS On Monday
www.forbes.com - November 16 at 6:15 PM
CVS: UndervaluedCVS: Undervalued
seekingalpha.com - November 16 at 1:13 PM
CVS system outages disrupts access to patient prescriptio...CVS system outages disrupts access to patient prescriptio...
finance.yahoo.com - November 16 at 1:13 PM
CVS Health Corp. :CVS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 16, 2017CVS Health Corp. :CVS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 16, 2017
finance.yahoo.com - November 16 at 1:13 PM
Better Buy: CVS Health Corporation vs. Wal-MartBetter Buy: CVS Health Corporation vs. Wal-Mart
www.fool.com - November 16 at 10:21 AM
CVS Health Corporation (CVS) Short Interest Up 16.1% in OctoberCVS Health Corporation (CVS) Short Interest Up 16.1% in October
www.americanbankingnews.com - November 15 at 3:00 AM
Drug Costs in the Spotlight With Trump’s Pick for Health SecretaryDrug Costs in the Spotlight With Trump’s Pick for Health Secretary
www.bloomberg.com - November 14 at 6:05 PM
Kiltearn Partners LLP Buys CVS Health Corp, General Electric Co, United Natural Foods Inc, ...Kiltearn Partners LLP Buys CVS Health Corp, General Electric Co, United Natural Foods Inc, ...
www.nasdaq.com - November 14 at 6:05 PM
Amazon Will Not Store or Ship Drugs: ReportAmazon Will Not Store or Ship Drugs: Report
finance.yahoo.com - November 14 at 6:05 PM
CVS Health Commits to Hiring 5,000 New Apprentices by 2022, Expands States Participating in the ProgramCVS Health Commits to Hiring 5,000 New Apprentices by 2022, Expands States Participating in the Program
finance.yahoo.com - November 14 at 6:05 PM
CVS Health announces plan to add 5,000 apprentices by 2022CVS Health announces plan to add 5,000 apprentices by 2022
finance.yahoo.com - November 14 at 6:05 PM
CVS Dividend Remains Safe - Q3 2017 UpdateCVS Dividend Remains Safe - Q3 2017 Update
seekingalpha.com - November 13 at 4:08 PM
CVS-Aetna deal 'really smart' way to ward off AmazonCVS-Aetna deal 'really smart' way to ward off Amazon
finance.yahoo.com - November 13 at 4:08 PM
CVS Health Corporation (CVS) Given Consensus Rating of "Buy" by AnalystsCVS Health Corporation (CVS) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - November 12 at 2:16 PM
Needham & Company LLC Upgrades CVS Health Corporation (CVS) to BuyNeedham & Company LLC Upgrades CVS Health Corporation (CVS) to Buy
www.americanbankingnews.com - November 12 at 1:10 PM
CVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in DelawareCVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in Delaware
finance.yahoo.com - November 11 at 5:34 PM
CVS Health’s Pharmacy and Retail Businesses: Lower 3Q17 MarginsCVS Health’s Pharmacy and Retail Businesses: Lower 3Q17 Margins
finance.yahoo.com - November 11 at 5:34 PM
CVS Plans Next-Day, Same-Day Prescription DeliveryCVS Plans Next-Day, Same-Day Prescription Delivery
finance.yahoo.com - November 11 at 5:34 PM
Strong 3Q17 Results Fail to Boost CVS Health’s Stock PriceStrong 3Q17 Results Fail to Boost CVS Health’s Stock Price
finance.yahoo.com - November 11 at 5:34 PM
CVS Health Earns Perfect Score in 2018 Corporate Equality IndexCVS Health Earns Perfect Score in 2018 Corporate Equality Index
finance.yahoo.com - November 11 at 5:34 PM
CVS-Aetna deal really smart way to ward off Amazon encroachment, analyst saysCVS-Aetna deal 'really smart' way to ward off Amazon encroachment, analyst says
finance.yahoo.com - November 11 at 5:34 PM
CVS Health Corporation (CVS) Expected to Announce Quarterly Sales of $47.72 BillionCVS Health Corporation (CVS) Expected to Announce Quarterly Sales of $47.72 Billion
www.americanbankingnews.com - November 10 at 11:33 AM
5 Things CVS Healths Management Just Said That Youll Want to Know5 Things CVS Health's Management Just Said That You'll Want to Know
finance.yahoo.com - November 9 at 12:14 AM
CVS Health Joins with the National Consortium of State-Operated Comprehensive Rehabilitation Centers to Help More Americans with Disabilities Find Meaningful EmploymentCVS Health Joins with the National Consortium of State-Operated Comprehensive Rehabilitation Centers to Help More Americans with Disabilities Find Meaningful Employment
finance.yahoo.com - November 9 at 12:14 AM
3Q17 Earnings: CVS Beats on Top and Bottom Lines3Q17 Earnings: CVS Beats on Top and Bottom Lines
finance.yahoo.com - November 9 at 12:14 AM
Pharmacy Drives CVS Health Top Line as Retail Segment StrugglesPharmacy Drives CVS Health Top Line as Retail Segment Struggles
finance.yahoo.com - November 9 at 12:14 AM
Cramer's lightning round: Step aside, Exxon. Cimarex's mo...Cramer's lightning round: Step aside, Exxon. Cimarex's mo...
finance.yahoo.com - November 9 at 12:14 AM
Q3 2018 Earnings Estimate for CVS Health Corporation (CVS) Issued By SunTrust BanksQ3 2018 Earnings Estimate for CVS Health Corporation (CVS) Issued By SunTrust Banks
www.americanbankingnews.com - November 8 at 7:00 PM
FY2017 EPS Estimates for CVS Health Corporation (CVS) Lifted by Oppenheimer HoldingsFY2017 EPS Estimates for CVS Health Corporation (CVS) Lifted by Oppenheimer Holdings
www.americanbankingnews.com - November 8 at 9:39 AM
Leerink Swann Equities Analysts Raise Earnings Estimates for CVS Health Corporation (CVS)Leerink Swann Equities Analysts Raise Earnings Estimates for CVS Health Corporation (CVS)
www.americanbankingnews.com - November 8 at 9:39 AM
Jefferies Group Weighs in on CVS Health Corporations FY2017 Earnings (CVS)Jefferies Group Weighs in on CVS Health Corporation's FY2017 Earnings (CVS)
www.americanbankingnews.com - November 8 at 9:38 AM
Drug distributor McKesson to buy CVS Healths services unit - ReutersDrug distributor McKesson to buy CVS Health's services unit - Reuters
www.reuters.com - November 8 at 6:02 AM
CVS Health (CVS) Beats Q3 Earnings Estimates, Updates View - NasdaqCVS Health (CVS) Beats Q3 Earnings Estimates, Updates View - Nasdaq
www.nasdaq.com - November 8 at 6:02 AM
Trade of the Day: CVS Health Corp (CVS) - Investorplace.comTrade of the Day: CVS Health Corp (CVS) - Investorplace.com
investorplace.com - November 8 at 6:02 AM
Sand In My Shoes - Stock Repair Strategy - Seeking AlphaSand In My Shoes - Stock Repair Strategy - Seeking Alpha
seekingalpha.com - November 8 at 6:02 AM
CVS Health Is Approaching A 3% Yield - Seeking AlphaCVS Health Is Approaching A 3% Yield - Seeking Alpha
seekingalpha.com - November 8 at 6:02 AM
Asian markets mixed after Wall Street declineAsian markets mixed after Wall Street decline
finance.yahoo.com - November 8 at 6:02 AM
Zacks: Brokerages Expect CVS Health Corporation (CVS) Will Announce Earnings of $1.91 Per ShareZacks: Brokerages Expect CVS Health Corporation (CVS) Will Announce Earnings of $1.91 Per Share
www.americanbankingnews.com - November 8 at 3:08 AM
Recent CVS NewsRecent CVS News
www.bloomberg.com - November 8 at 12:57 AM
McKesson Targets Specialty Pharma Growth with Deal for CVSs RxCrossroadsMcKesson Targets Specialty Pharma Growth with Deal for CVS's RxCrossroads
finance.yahoo.com - November 8 at 12:57 AM
Six Ways Amazon Could Invade the Pharmacy BusinessSix Ways Amazon Could Invade the Pharmacy Business
finance.yahoo.com - November 8 at 12:57 AM
Leerink Swann Reiterates "Outperform" Rating for CVS Health Corporation (CVS)Leerink Swann Reiterates "Outperform" Rating for CVS Health Corporation (CVS)
www.americanbankingnews.com - November 7 at 12:08 PM
CVS Health Corp. Profit Falls 13% In Q3CVS Health Corp. Profit Falls 13% In Q3
www.nasdaq.com - November 7 at 6:04 AM
CVS Health Corporation 2017 Q3 - Results - Earnings Call SlidesCVS Health Corporation 2017 Q3 - Results - Earnings Call Slides
seekingalpha.com - November 6 at 11:59 PM
CVS plans free same-day delivery in some cities, next-day delivery nationwideCVS plans free same-day delivery in some cities, next-day delivery nationwide
www.latimes.com - November 6 at 11:59 PM

Social Media

Financials

Chart

CVS Health Corporation (NYSE CVS) Chart for Tuesday, November, 21, 2017
Loading chart…

This page was last updated on 11/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.